Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| CRKL | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 1.22E5 | Evidence | |||||
| CRKL | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 9.84E4 | Evidence |
O
|
||||
| CRKL | KIT | KIT: Mast/stem cell growth factor receptor precursor | 8.90E4 | Evidence |
O
|
||||
| CRKL | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 6.45E4 | Evidence |
|
||||
| CRKL | INSR | INSR: Insulin receptor precursor | 6.35E4 | Evidence |
|
||||
| CRKL | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 5.39E4 | Evidence | |||||
| CRKL | NCK2 | NCK2: Cytoplasmic protein NCK2 | 1.50E4 | Evidence | |||||
| CRKL | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 1.07E4 | Evidence | |||||
| CRKL | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 7.83E3 | Evidence | |||||
| CRKL | WASPIP | N/A | 3.35E3 | Evidence |
|
||||
| CRKL | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 3.35E3 | Evidence |
O
|
||||
| CRKL | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 2.03E3 | Evidence | |||||
| CRKL | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 2.01E3 | Evidence |
O
|
||||
| CRKL | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 816.0 | Evidence | |||||
| CRKL | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 688.0 | Evidence | |||||
| CRKL | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 674.0 | Evidence | |||||
| CRKL | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 519.0 | Evidence | |||||
| CRKL | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 455.0 | Evidence | |||||
| CRKL | CSK | CSK: Tyrosine-protein kinase CSK | 408.0 | Evidence | |||||
| CRKL | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 407.0 | Evidence | |||||
| CRKL | SYK | SYK: Tyrosine-protein kinase SYK | 407.0 | Evidence |
|
||||
| CRKL | JAK1 | 407.0 | Evidence | ||||||
| CRKL | CTTN | CTTN, EMS1: Src substrate cortactin | 331.0 | Evidence | |||||
| CRKL | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 320.0 | Evidence | |||||
| CRKL | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 275.0 | Evidence |
|
||||
| CRKL | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 275.0 | Evidence | |||||
| CRKL | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 268.0 | Evidence |
|
||||
| CRKL | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence | |||||
-